Boosting the apoptotic response of high‐grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro‐survival protein MCL‐1 by Raab, Monika, Kobayashi, Nene F., Becker, Sven, Kurunci‐Csacsko, Elisabeth, Krämer, Andrea, Strebhardt, Klaus, Sanhaji, Mourad

Get full text

PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells by Raab, Monika, Sanhaji, Mourad, Matthess, Yves, Hörlin, Albrecht, Lorenz, Ioana, Dötsch, Christina, Habbe, Nils, Waidmann, Oliver, Kurunci-Csacsko, Elisabeth, Firestein, Ron, Becker, Sven, Strebhardt, Klaus

Get full text

Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRA... by Gasimli, Khayal, Raab, Monika, Tahmasbi Rad, Morva, Kurunci-Csacsko, Elisabeth, Becker, Sven, Strebhardt, Klaus, Sanhaji, Mourad

Get full text

Optimized Plk1 PBD Inhibitors Based on Poloxin Induce Mitotic Arrest and Apoptosis in Tumor Cells by Scharow, Andrej, Raab, Monika, Saxena, Krishna, Sreeramulu, Sridhar, Kudlinzki, Denis, Gande, Santosh, Dötsch, Christina, Kurunci-Csacsko, Elisabeth, Klaeger, Susan, Kuster, Bernhard, Schwalbe, Harald, Strebhardt, Klaus, Berg, Thorsten

Get full text

Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles by Spänkuch, Birgit, Steinhauser, Isabel, Wartlick, Heidrun, Kurunci-Csacsko, Elisabeth, Strebhardt, Klaus I, Langer, Klaus

Get full text

Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1 by Raab, Monika, Krämer, Andrea, Hehlgans, Stephanie, Sanhaji, Mourad, Kurunci-Csacsko, Elisabeth, Dötsch, Christina, Bug, Gesine, Ottmann, Oliver, Becker, Sven, Pachl, Fiona, Kuster, Bernhard, Strebhardt, Klaus

Request full text

Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells by Raab, Monika, Pachl, Fiona, Krämer, Andrea, Kurunci-Csacsko, Elisabeth, Dötsch, Christina, Knecht, Rainald, Becker, Sven, Kuster, Bernhard, Strebhardt, Klaus

Get full text

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells by Raab, Monika, Kappel, Sven, Krämer, Andrea, Sanhaji, Mourad, Matthess, Yves, Kurunci-Csacsko, Elisabeth, Calzada-Wack, Julia, Rathkolb, Birgit, Rozman, Jan, Adler, Thure, Busch, Dirk H., Esposito, Irene, Fuchs, Helmut, Gailus-Durner, Valérie, Klingenspor, Martin, Wolf, Eckhard, Sänger, Nicole, Prinz, Florian, Angelis, Martin Hrabě de, Seibler, Jost, Yuan, Juping, Bergmann, Martin, Knecht, Rainald, Kreft, Bertolt, Strebhardt, Klaus

Get full text

Down-regulation of polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo by SPÄNKUCH, Birgit, HEIM, Sandra, KURUNCI-CSACSKO, Elisabeth, LINDENAU, Christine, JUPING YUAN, KAUFMANN, Manfred, STREBHARDT, Klaus

Get full text

Quantitative chemical proteomics reveals a Plkl inhibitor-compromised cell death pathway in human cells by Monika Raab Fiona Pachl Andrea Kraemer Elisabeth Kurunci-Csacsko Christina Doetsch Rainald Knecht Sven Becker Bernhard Kuster Klaus Strebhardt

Get full text

Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles1 by Spänkuch, Birgit, Steinhauser, Isabel, Wartlick, Heidrun, Kurunci-Csacsko, Elisabeth, Strebhardt, Klaus I, Langer, Klaus

Get full text